Biosynex (ALBIO) — Cash Flow Reinvestment Rate
Biosynex (ALBIO) has a Cash Flow Reinvestment Rate of 2.19x as of December 2024, reinvesting €2.77 Million (capex €2.77 Million ) from operating cash flow of €1.26 Million. Check Biosynex earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Biosynex Cash Flow Reinvestment Rate (2009–2022)
Historical reinvestment intensity for Biosynex across 9 annual periods. Explore how much of Biosynex's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Biosynex (2009–2022)
Year-by-year capital reinvestment analysis for Biosynex. For live market cap and broader valuation context, see Biosynex market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 13.98x | €69.16 Million | €4.95 Million | €30.08 Million | ▲ +3101.6% |
| 2021 | 0.44x | €47.98 Million | €109.83 Million | €19.02 Million | ▼ -18.9% |
| 2020 | 0.54x | €17.04 Million | €31.64 Million | €9.12 Million | ▼ -93.5% |
| 2019 | 8.26x | €9.12 Million | €1.10 Million | €9.12 Million | ▼ -57.7% |
| 2018 | 19.52x | €9.12 Million | €467.12K | €9.12 Million | ▲ +3.8% |
| 2017 | 18.81x | €9.12 Million | €484.82K | €9.12 Million | — |
| 2016 | 0.00x | €0.00 | €489.91K | €0.00 | — |
| 2015 | 0.00x | €0.00 | €461.66K | €0.00 | ▼ -100.0% |
| 2009 | 0.65x | €46.92K | €72.40K | €46.92K | — |